Grant of Stock Acquisition Rights to Directors and Executive Officers, etc.
First written in FY2017-Q2. 7 of 9 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2023.
The whole theme swung hardest in 2024: 4 of 31 companies on the "Worse" side.
11 other companies' latest entry also says "Dropped".
- FY2023DroppedAnnual report
「We will no longer allocate new stock acquisition rights. However, any stock acquisition rights already granted to the company's directors that have not been exercised will remain in effect.」
The company explicitly stated its policy of making no further grants of stock acquisition rights to directors and others. However, previously issued and unexercised stock acquisition rights will remain in effect. - FY2023-Q2AdvancedAnnual report
「Resolution date: 5 July 2022. Categories and number of grantees: 3 company directors; 14 company executive officers; 6 directors of subsidiaries. Number of stock acquisition rights: 864 (Note 1). Class, description and number of shares underlying the stock acquisition rights: common shares, 86,400 shares (Note 1). Exercise period: 22 July 2022 to 21 July 2072」
Newly granted 864 stock acquisition rights, representing 86,400 underlying shares, to directors, executive officers and subsidiary directors. - FY2022AdvancedAnnual report
「Status of disposition and holdings of treasury shares: Other (exercise of stock acquisition rights), 118,000, 337,563」
While continuing to grant stock acquisition rights to officers and others, treasury shares decreased by 118,000 during the fiscal year as a result of the exercise of stock acquisition rights. - FY2022-Q2AdvancedAnnual report
「Resolution date: 5 July 2021. Categories and number of grantees: 3 company directors; 10 company executive officers; 8 directors of subsidiaries. Number of stock acquisition rights: 942 (Note 1). Class, description and number of shares underlying the stock acquisition rights: common shares, 94,200 shares (Note 1). Exercise period: 22 July 2021 to 21 July 2071」
Granted 942 stock acquisition rights, representing 94,200 underlying shares, to directors, executive officers and subsidiary directors. This was a new grant following the grants made to date. - FY2021-Q2AdvancedAnnual report
「Resolution date: 2 July 2020. Categories and number of grantees: 4 company directors; 11 company executive officers; 11 directors of subsidiaries. Number of stock acquisition rights: 1,198 (Note 1). Class, description and number of shares underlying the stock acquisition rights: common shares, 119,800 shares (Note 1). Exercise period: 18 July 2020 to 17 July 2070」
Granted 1,198 stock acquisition rights, representing 119,800 underlying shares, to directors, executive officers and subsidiary directors. This was a specific grant following the previous grant. - FY2020-Q2AdvancedAnnual report
「Categories and number of grantees: 3 company directors; 11 company executive officers; 17 directors of subsidiaries. Number of stock acquisition rights: 827 (Note 1). Class, description and number of shares underlying the stock acquisition rights: common shares, 82,700 shares (Note 1). Exercise period: 20 July 2019 to 19 July 2069」
Granted 827 stock acquisition rights, representing 82,700 underlying shares, to directors, executive officers and subsidiary directors. This was a specific grant following the previous grant. - FY2019-Q2AdvancedAnnual report
「Categories and number of grantees: 3 company directors; 11 company executive officers; 17 directors of subsidiaries. Number of stock acquisition rights: 782 (Note 1). Class, description and number of shares underlying the stock acquisition rights: common shares, 78,200 shares (Note 1). Exercise period: 21 July 2018 to 20 July 2028」
Based on the resolution dated 4 July 2018, granted 782 stock acquisition rights, representing 78,200 underlying shares, to directors, executive officers and subsidiary directors. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter of the current fiscal year are as follows: Number of stock acquisition rights: 969 (Note 1); number of shares underlying the stock acquisition rights: 96,900 (Note 1); exercise period: 22 July 2017 to 21 July 2027」
Issued 969 stock acquisition rights, representing 96,900 underlying shares, for directors, audit & supervisory board members, executive officers and others. This was a specific grant following the grant described previously. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter of the current fiscal year are as follows: Number of stock acquisition rights: 983; number of shares underlying the stock acquisition rights: 98,300; exercise period: 22 July 2016 to 21 July 2026」
Issued 983 stock acquisition rights for directors, audit & supervisory board members, executive officers and others, with exercise conditions based on the exercise period and period of service.